Cross-reactive tissue-resident CD8+ T cells may provide first line of defence against SARS-CoV-2
Crossref DOI link: https://doi.org/10.1038/s41577-021-00638-4
Published Online: 2021-10-05
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Flemming, Alexandra
Text and Data Mining valid from 2021-10-05
Version of Record valid from 2021-10-05
Article History
First Online: 5 October 2021
Free to read: This content has been made available to all.